Am. J. Respir. Cell Mol. Biol., Volume 18, Number 4, April, 1998 489-496

Macrophage-stimulating Protein and Its Receptor in Non-small-cell Lung Tumors: Induction of Receptor Tyrosine Phosphorylation and Cell Migration

Christopher G. Willett, Ming-Hai Wang, Rodica L. Emanuel, Sherry A. Graham, David I. Smith, Viji Shridhar, David J. Sugarbaker, and Mary E. Sunday

Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Wayne State University, Detroit, Michigan; Department of Medicine, Children's Hospital and Harvard Medical School, Departments of Pathology, Internal Medicine, Molecular Biology and Genetics, and Surgery, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts; and Department of Experimental Pathology, Mayo Foundation, Rochester, Minnesota

Previously, we identified macrophage-stimulating protein (MSP) as being expressed during hamster lung injury induced by nitrosamine carcinogens. Transient, generalized epithelial-cell hyperplasia during the preneoplastic period, and eventually nonneuroendocrine (non-NE) lung tumors, are known to develop in these nitrosamine-treated hamsters. We wished to test the hypothesis that MSP and its tyrosine kinase receptor, RON, might represent an autocrine/paracrine system involved in the pathogenesis of human nonneuroendocrine lung tumors, the non-small-cell carcinomas (NSCLCs). We found that this occurred in a paracrine fashion in three of eight primary human NSCLCs that expressed messenger RNA (mRNA) for MSP at high levels in histologically normal lung adjacent to the tumor, but not in the primary tumor, together with mRNA for RON in both normal and tumor tissue. MSP and RON could also constitute an autocrine/paracrine system in human NSCLC cell lines: five of 16 cell lines (squamous and adenosquamous) expressed both MSP and RON; and an additional five of 16 cell lines expressed RON without detectable MSP. Although three cases of primary squamous-cell carcinomas expressed MSP (two of three in the tumor and one of three in nonneoplastic lung), mRNA for RON was not detectable in these cases. RON was functional in all tested RON mRNA-positive cell lines, with exogenous MSP inducing RON-mediated tyrosine phosphorylation. Treatment of a RON-positive adenosquamous carcinoma cell line with MSP additionally resulted in increased motility in a cell-migration assay, suggesting that MSP might promote cell migration of some NSCLCs. In conclusion, MSP and RON might represent an autocrine/paracrine system involved in the pathogenesis of lung cancer, although the nature of the biologic responses in different cell types might vary considerably.

This article has been cited by other articles:

				P. S. Hodkinson, A. MacKinnon, and T. Sethi Targeting Growth Factors in Lung Cancer Chest, May 1, 2008; 133(5): 1209 - 1216. [Abstract] [Full Text] [PDF]

				A. Thangasamy, J. Rogge, and S. Ammanamanchi Regulation of RON Tyrosine Kinase-mediated Invasion of Breast Cancer Cells J. Biol. Chem., February 29, 2008; 283(9): 5335 - 5343. [Abstract] [Full Text] [PDF]

				T. Rampino, G. Soccio, M. Gregorini, C. Guidetti, M. Marasa, M. Maggio, V. Panichi, M. Migliori, C. Libetta, and A. Dal Canton Neutralization of Macrophage-Stimulating Protein Ameliorates Renal Injury in Anti-Thy 1 Glomerulonephritis J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1486 - 1496. [Abstract] [Full Text] [PDF]

				J. M. O'Toole, K. E. Rabenau, K. Burns, D. Lu, V. Mangalampalli, P. Balderes, N. Covino, R. Bassi, M. Prewett, K. J. Gottfredsen, et al. Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member. Cancer Res., September 15, 2006; 66(18): 9162 - 9170. [Abstract] [Full Text] [PDF]

				S. Germano, D. Barberis, M. M. Santoro, L. Penengo, A. Citri, Y. Yarden, and G. Gaudino Geldanamycins Trigger a Novel Ron Degradative Pathway, Hampering Oncogenic Signaling J. Biol. Chem., August 4, 2006; 281(31): 21710 - 21719. [Abstract] [Full Text] [PDF]

				B. E. Peace, K. Toney-Earley, M. H. Collins, and S. E. Waltz Ron Receptor Signaling Augments Mammary Tumor Formation and Metastasis in a Murine Model of Breast Cancer Cancer Res., February 15, 2005; 65(4): 1285 - 1293. [Abstract] [Full Text] [PDF]

				D. Angeloni, A. Danilkovitch-Miagkova, A. Miagkov, E. J. Leonard, and M. I. Lerman The Soluble Sema Domain of the RON Receptor Inhibits Macrophage-stimulating Protein-induced Receptor Activation J. Biol. Chem., January 30, 2004; 279(5): 3726 - 3732. [Abstract] [Full Text] [PDF]

				Y.-Q. Chen, Y.-Q. Zhou, L.-H. Fu, D. Wang, and M.-H. Wang Multiple pulmonary adenomas in the lung of transgenic mice overexpressing the RON receptor tyrosine kinase Carcinogenesis, November 1, 2002; 23(11): 1811 - 1819. [Abstract] [Full Text] [PDF]

				T. Rampino, C. Collesi, M. Gregorini, M. Maggio, G. Soccio, P. Guallini, and A. D. Canton Macrophage-Stimulating Protein Is Produced by Tubular Cells and Activates Mesangial Cells J. Am. Soc. Nephrol., March 1, 2002; 13(3): 649 - 657. [Abstract] [Full Text] [PDF]

				M. C. Stella, A. Vercelli, M. Repici, A. Follenzi, and P. M. Comoglio Macrophage Stimulating Protein Is a Novel Neurotrophic Factor Mol. Biol. Cell, May 1, 2001; 12(5): 1341 - 1352. [Abstract] [Full Text]